DigestRedComo funciona
Digest/ Comunicado

Compatibilidad
Ahorrar()
Compartir
Detalles de contacto
¿Quieres ver los próximos lanzamientos de este profesional en tu resumen?

Comunicados relacionados

01/06/2026
Ciencia
Biotecnología
Farmacéutica
Oncología
Sanidad
Salud
Medicina - Varios
Eventos
Industria
Convergent Therapeutics Announces Positive Phase 2 Data at ASCO 2026 Showing Promising Anti-Tumor Activity, Durability, and Favorable Tolerability for CONV01-α in Lu-PSMA-Exposed Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Fuente
Convergent Therapeutics Inc.
Editor
Business Wire
0
21/04/2026
Eventos
Finanzas
Industria
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Convergent Therapeutics to Present Phase 2 Data for CONV01-α in Lu-PSMA pretreated Metastatic Castration-Resistant Prostate Cancer Patients at the 2026 ASCO Annual Meeting
Fuente
Convergent Therapeutics Inc.
Editor
Business Wire
0
19/03/2026
Convergent Therapeutics Appoints Radiopharmaceutical Industry Veteran Michael Rossi to its Board of Directors
Fuente
Convergent Therapeutics Inc.
Editor
Business Wire
0